Two better than one in HER2 blockade 9 Dec 2011 0 comments Adding pertuzumab to trastuzumab and docetaxel chemotherapy extends progression free survival by 6 months in patients with metastatic HER2 positive cancer.
No green light for food labelling 2 Dec 2011 0 comments The AMA has accused the Government of caving in to the food industry after failing to endorse traffic light labelling for foods.
ADT alone 'not adequate' in high-risk prostate cancer 4 Nov 2011 0 comments Adding radiotherapy to androgen deprivation therapy improves survival in men with locally advanced prostate cancer.
Regulatory shortfalls still putting patients at risk 4 Nov 2011 0 comments A lack of scrutiny of diagnostic and screening devices continues to undermine public safety, experts say.
Thyroid cancer rise partly explained by diagnostic changes 28 Oct 2011 0 comments The rise in thyroid cancer in NSW can only partly be explained by improvements in diagnostic technology and surveillance, endocrinologists say.
Latest research 'reassuring' on mobile-brain cancer link 21 Oct 2011 0 comments A large study has given some reassurance over the safety of mobile phones, but a link with cancer is still possible, experts say.
Modern radiotherapy methods do not increase cardiac mortality 21 Oct 2011 0 comments Modern methods of radiotherapy (RT) for breast cancer do not increase cardiac mortality, a study of NSW patients has shown.
Vitamin E linked to prostate cancer 14 Oct 2011 0 comments A study that set out to see if vitamin E supplements would protect against prostate cancer has found it raised the risk by 17%.
Choice of antiepileptic may affect survival in glioblastoma 16 Sep 2011 0 comments The choice of antiepileptic drug in patients with glioblastoma may be more important than previously thought, research suggests.
Personalised bowel cancer treatment on PBS 1 Sep 2011 0 comments As of the 1st September Erbitux (cetuximab) will be available on the PBS for patients with KRAS wild-type metastatic colorectal cancer who have not responded to first line chemotherapy.